Cargando…
Bench to Bedside: Proteomic Biomarker Analysis of Cerebrospinal Fluid in Patients With Spondylomyelopathy
Establishing proteomic biomarkers is critical for characterizing disease pathophysiology, identifying genetic risk factors, and predicting clinical outcomes. However, diseases like cervical spondylomyelopathy have not been actively characterized for molecular significance, leading to questions regar...
Autores principales: | Fiani, Brian, Covarrubias, Claudia, Jarrah, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319193/ https://www.ncbi.nlm.nih.gov/pubmed/34336494 http://dx.doi.org/10.7759/cureus.16003 |
Ejemplares similares
-
Genetic Predictors of Early-Onset Spinal Intervertebral Disc Degeneration: Part One of Two
por: Fiani, Brian, et al.
Publicado: (2021) -
Genetic Predictors of Early-Onset Spinal Intervertebral Disc Degeneration: Part Two of Two
por: Fiani, Brian, et al.
Publicado: (2021) -
Cytokine Concentrations in the Cerebrospinal Fluid of Great Danes with Cervical Spondylomyelopathy
por: Martin‐Vaquero, P., et al.
Publicado: (2014) -
MicroRNA expression in the cerebrospinal fluid of dogs with and without cervical spondylomyelopathy
por: Vansteenkiste, Daniella P., et al.
Publicado: (2019) -
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
por: Pawlowski, Matthias, et al.
Publicado: (2017)